OxThera's Grant

OxThera raised a round of funding on September 25, 2013. Investors include Seventh Framework Programme.

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera's intellectual property includes worldwide patents for …

Articles about OxThera's Grant: